Prospective observational study in patients with spinal and bulbar muscular atrophy (SBMA) who completed the phase 3 clinical trial of TAP-144-SR (3M) .
Not Applicable
- Conditions
- Spinal and Bulbar Muscular Atrophy
- Registration Number
- JPRN-UMIN000003444
- Lead Sponsor
- eurology, the University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Patients judged as inappropriate to this study by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Motor functions and QOL (videofluorographic and manometric examination of swallowing, 6-minute walk, ALSFRS-R, QMG Score, ALSAQ-5)
- Secondary Outcome Measures
Name Time Method Blood Pressure, Body Weight, Bone Mineral Density, Serum Creatine Kinase, Testosterone, Blood Glucose, HbA1c